3 test combo to treat AD?

Share this article:

Combining diagnostic tests that include imaging and cerebrospinal fluid biomarkers can improve prediction of a patient progressing from mild cognitive impairment to Alzheimer's disease, according to a study published Dec. 11 in Radiology.

Duke Medicine researchers reviewed three tests — magnetic resonance imaging (MRI), fluorine 18 fluorodeoxyglucose positron emission tomography (FDG-PET), and cerebrospinal fluid analysis — to learn whether the trio were more accurate than single tests. The study subjects also were given routine clinical exams.

Share this article:
close

Next Article in News

More in News

CMS needs to get nursing home staffing information directly from payroll systems, Congressional leaders say

CMS needs to get nursing home staffing information ...

Federal regulators should start collecting nursing home staffing information directly from payroll systems as soon as possible, members of the Congressional Seniors Task Force said in a letter to a ...

Male CNA who wears women's clothing can pursue charges that nursing home ...

A Texas certified nursing assistant can continue to pursue charges that his former nursing home employer has made false, defamatory statements about him in the job referral process, a federal court recently ruled.

High-profile consumer advocacy group sues over broken Medicare appeals process

Long-term care providers have been outspoken in their criticism of the Medicare appeals process, which has all but ground to a halt. Now a class-action lawsuit says Medicare beneficiaries also are being harmed by the excessively long delays.